Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerdulatinib in R/R CLL/SLL or NHL
NCT01994382Phase 2Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Aug 2013
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cerdulatinib in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), sponsored by Alexion Pharmaceuticals. Started Aug 2013; status: completed.
02
Drugs
cerdulatinib
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)follicular lymphoma (FL)diffuse large B-cell lymphoma (DLBCL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01994382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01994382.